Blood Cell Biochemistry

Hematopoiesis and Gene Therapy

AvLeslie J. Fairbairn,Nydia G. Testa

Inbunden, Engelska, 1999

Del i serien Blood Cell Biochemistry

1 632 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

This volume, the last in the Blood Cell Biochemistry series, focuses specifically on gene therapy in the haematopietic system, its applications, potentials and problems, and provides insight into how the haematopietic system may be considered as a target in therapy of acquired and inherited disease of other tissues.

Produktinformation

Utgivningsdatum:1999-03-31
Mått:178 x 254 x 27 mm
Vikt:954 g
Format:Inbunden
Språk:Engelska
Serie:Blood Cell Biochemistry
Antal sidor:380
Upplaga:1999
Förlag:Springer Science+Business Media
ISBN:9780306459627

Utforska kategorier

Klinisk medicin och internmedicin inom Medicin
Anatomi inom Medicin

Innehållsförteckning

1 Hemopoietic Stem Cells as Targets for Genetic Manipulation: Concepts and Practical Approaches.- 1. How Many Stem Cells Do We Need?.- 2. Selection and Identification by Phenotype and Function.- 3. Sources of Primitive Hematopoietic Cells.- 4. How Can We Maximize the Number of Target Cells?.- 5. Concluding Comments.- 6. References.- 2 Bone Marrow Transplantation for Genetic Diseases.- 1. Introduction.- 2. General Principles of BMT.- 3. The Bone Marrow Transplantation Process.- 4. Complications of BMT.- 5. Results of BMT.- 6. Future Directions.- 7. References.- 3 Retroviral Vectors.- 1. Why Retroviruses?.- 2. The Basic Vector.- 3. The Packaging Cell.- 4. References.- 4 Parvoviral Vectors for Human Hematopoietic Gene Therapy.- 1. Introduction.- 2. Life Cycle of Human Parvoviruses.- 3. Recombinant Parvoviral Vectors.- 4. Parvovirus-Mediated Transduction and Expression of Genes.- 5. Advantages and Disadvantages of Parvovirus Vectors.- 6. Summary and Conclusions.- 7. Future Prospects.- 8. References.- 5 Nonviral Methods for Gene Transfer.- 1. Introduction.- 2. Plasmid DNA-Based Methods.- 3. Artificial Self-Assembling Systems.- 4. References.- 6 Prospects for Gene Therapy of Inherited Immunodeficiency.- 1. Introduction to Gene Therapy.- 2. Immunodeficiency Disorders.- 3. Vector Systems and Their Suitability for Gene Therapy of Immunodeficiency.- 4. Gene Therapy for Immunodeficiency Disorders.- 5. Conclusion.- 6. References.- 7 Gene Therapy for Lysosomal Disorders.- 1. Defining a Population of Patients Suitable for Treatment.- 2. Gene Therapy.- 3. Targeting the Brain.- 4. Conclusions.- 5. References.- 8 Genetic Approaches to Therapy for the Hemoglobinopathies.- 1. Introduction.- 2. Current Therapies for ?-Thalassaemia.- 3. Current Therapies for Sickle Cell Disease.- 4.Regulation of Gene Expression from the Human ?-Globin Locus.- 5. Pharmaceutical Activation of Fetal ?-Globin Gene Expression in the Adult.- 6. Gene Therapy.- 7. Summary and Future Prospects.- 8. References.- 9 Gene Marking and the Biology of Hematopoietic Cell Transfer in Human Clinical Trials.- 1. Introduction.- 2. Gene Marking and Cancer Biology.- 3. Retroviral Marking of Tumor-Infiltrating Lymphocytes.- 4. Clinical Trials of Stem Cell Gene Marking.- 5. Clinical Trial Design.- 6. Retroviral Marking of Malignant Cells.- 7. Clinical Trial Results.- 8. Hematopoiesis and Gene Marking.- 9. Genetically Marked Relapse.- 10. Retroviral Gene Marking and Purging Efficacy.- 11. Implications of Gene Marking Results in Clinical Practice.- 12. In Vitro Strategies to Improve Hematopoietic Stem Cell Targeting.- 13. Future Directions.- 14. Summary.- 15. References.- 10 Antisense Strategies to Leukemia.- 1. Introduction.- 2. Antisense and Ribozymal Design and Mechanisms of Action.- 3. Controls, Experimental Systems, and Difficulties in Interpretation.- 4. Antisense and Ribozymes in Experimental Hematology.- 5. Clinical Trials in Hematology.- 6. Future Prospects.- 7. References.- 11 Transfer of Drug Resistance Genes into Bone Marrow Stem and Progenitor Cells: Implications for Cancer Chemotherapy.- 1. Introduction.- 2. Current Strategies for Hematopoietic Support during Chemotherapy.- 3. Gene Transfer, Expression, and Stem Cell Protection.- 4. Further Considerations.- 5. Concluding Remarks.- 6. References.- 12 HIV Gene Therapy Using Hairpin Ribozymes in Hematopoietic Stem/Progenitor Cells.- 1. Ribozyme for Gene Therapy of AIDS.- 2. Gene Therapy Using Hematopoietic Stem/Progenitor Cells.- 3. Transduction of Stem/Progenitor Cells Using Ribozymal Constructs.- 4. Toward Clinical Trials.-5. References.- 13 Molecular Immunotherapy by Gene Transfer.- 1. Introduction.- 2. Are Tumors Antigenic?.- 3. Antigen Presentation Pathways.- 4. Immunotherapy by Gene Transfer.- 5. Aims, Goals, and Targets for Gene Transfer in Immunotherapy.- 6. Unification of Diverse Results from Gene Transfer Studies.- 7. References.- 14 DNA-Based Immunization.- 1. Introduction.- 2. DNA Vaccines for Protection against Infectious Diseases.- 3. DNA Vaccines for Immunotherapy.- 4. Mechanism of Induction of Immune Responses.- 5. Safety Considerations.- 6. Summary and Future Directions.- 7. Implications for Gene Therapy.- 8. References.